Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PEXIDARTINIB Cause Gamma-glutamyltransferase increased? 78 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Gamma-glutamyltransferase increased have been filed in association with PEXIDARTINIB (Turalio). This represents 8.0% of all adverse event reports for PEXIDARTINIB.

78
Reports of Gamma-glutamyltransferase increased with PEXIDARTINIB
8.0%
of all PEXIDARTINIB reports
1
Deaths
10
Hospitalizations

How Dangerous Is Gamma-glutamyltransferase increased From PEXIDARTINIB?

Of the 78 reports, 1 (1.3%) resulted in death, 10 (12.8%) required hospitalization.

Is Gamma-glutamyltransferase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PEXIDARTINIB. However, 78 reports have been filed with the FAERS database.

What Other Side Effects Does PEXIDARTINIB Cause?

Fatigue (378) Product dose omission issue (335) Hair colour changes (327) Nausea (213) Pruritus (186) Aspartate aminotransferase increased (134) Rash (131) Off label use (130) Alanine aminotransferase increased (124) Diarrhoea (106)

What Other Drugs Cause Gamma-glutamyltransferase increased?

FINGOLIMOD (635) ACETAMINOPHEN (442) METHOTREXATE (421) ATORVASTATIN (376) RIBOCICLIB (375) LETROZOLE (323) DEXAMETHASONE (292) CYCLOPHOSPHAMIDE (277) CARBOPLATIN (262) NIVOLUMAB (261)

Which PEXIDARTINIB Alternatives Have Lower Gamma-glutamyltransferase increased Risk?

PEXIDARTINIB vs PHENACETIN PEXIDARTINIB vs PHENAZOPYRIDINE PEXIDARTINIB vs PHENCYCLIDINE PEXIDARTINIB vs PHENELZINE PEXIDARTINIB vs PHENOBARBITAL

Related Pages

PEXIDARTINIB Full Profile All Gamma-glutamyltransferase increased Reports All Drugs Causing Gamma-glutamyltransferase increased PEXIDARTINIB Demographics